Loxo Oncology (LOXO) Priced

Early-stage biotech developing targeted therapies to treat solid tumors.

Health Care - Biotechnology

IPO Performance
Latest Trade $45.41 0.00 (0.0%)
First Day Return 0.0%
Return from IPO 249.3%
 
Loxo Oncology IPO News more
  • .
IPO Data
IPO File Date 06/30/2014
Offer Price $13.00
Price Range $12.00 - $14.00
Offer Shares (mm) 5.3
Deal Size ($mm) 68
 
IPO Data
IPO Date 07/31/2014
Offer Price $13.00
Price Range $12.00 - $14.00
Offer Shares (mm) 5.3
Deal Size ($mm) $68
 
Underwriters
more
Business Overview
Early-stage biotech developing targeted therapies to treat solid tumors.
Early-stage biotech developing targeted therapies to treat solid tumors.
more
Company Data
Headquarters Stamford, CT
Founded 2013
Employees 9
Website www.loxooncology.com
 

Performance vs. IPO Index (IPOUSA)